Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Patent
1996-06-21
1998-11-03
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
424482, 424481, 424462, 424461, 424458, 424457, 424456, A61K 932, A61K 934, A61K 936, A61K 956
Patent
active
058305033
ABSTRACT:
A once-a-day diltiazem dosage form which comprises: (a) a core element which is a compressed tablet which contains a therapeutic dose of diltiazem and an amount of a solubility modulating substance that controls the release of said diltiazem in order to provide a therapeutic level over a period of about 24 hours; and (b) on the outer surface of the core element, a sufficient amount of an enteric coating that causes the diltiazem to release at a rate that permits the use of once-a-day dosing to maintain steady state therapeutic levels of diltiazem.
REFERENCES:
patent: 4839177 (1989-06-01), Colombo et al.
patent: 4891230 (1990-01-01), Geoghegan et al.
patent: 4894240 (1990-01-01), Geoghegan et al.
patent: 4917899 (1990-04-01), Geoghegan et al.
patent: 4963365 (1990-10-01), Samejima et al.
patent: 5002776 (1991-03-01), Geoghegan et al.
patent: 5051262 (1991-09-01), Panoz et al.
patent: 5112621 (1992-05-01), Stevens et al.
patent: 5137733 (1992-08-01), Noda et al.
patent: 5149542 (1992-09-01), Valducci
patent: 5229135 (1993-07-01), Philippon et al.
patent: 5286497 (1994-02-01), Hendrickson et al.
patent: 5288505 (1994-02-01), Deboeck et al.
patent: 5336504 (1994-08-01), Geoghegan et al.
patent: 5344657 (1994-09-01), Desmolin
patent: 5364620 (1994-11-01), Geoghegan et al.
patent: 5376384 (1994-12-01), Eichel et al.
patent: 5419917 (1995-05-01), Chen et al.
patent: 5422123 (1995-06-01), Conte et al.
patent: 5472710 (1995-12-01), Klokkers-Bethke et al.
patent: 5529790 (1996-06-01), Eichel et al.
patent: 5578321 (1996-11-01), Sherman
Andrx Pharmaceuticals Inc.
Page Thurman K.
Spear James M.
LandOfFree
Enteric coated diltiazem once-a-day formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enteric coated diltiazem once-a-day formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enteric coated diltiazem once-a-day formulation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-686866